{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/27/3263751/0/en/ORIC-Pharmaceuticals-to-Report-Combination-Dose-Optimization-Data-From-Phase-1b-Trial-of-Rinzimetostat-in-Patients-with-mCRPC.html", "message": "News view counter 628919 successfully enlarged"}